Skip directly to site content Skip directly to search
Español | Other Languages
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Viral Hepatitis
    CDC Home
    • Facebook
    • Twitter
    • LinkedIn
    • Syndicate

    2020 Viral Hepatitis Surveillance Report Appendix

    Minus
    Related Pages
    2020 Viral Hepatitis Surveillance Report Appendix
    Figures
    • Figure 5.1. Number of reported acute hepatitis B and hepatitis C cases (Panel A) and estimated infections (Panel B) among adults aged 18-40 years old — United States, 2013-2020
    Tables
    • Table 5.1. Number of reported acute viral hepatitis cases and estimated infections with 95% bootstrap confidence intervals — United States, 2013-2020
    • Table 5.2. Number of reported acute and chronic cases of hepatitis C virus infection by case status — United States, 2020
    • Table 5.3. Numbers and rates of reported acute hepatitis infections among adults aged 18-40 years old, by demographic characteristics — United States 2020
    Page last reviewed: August 18, 2022
    Content source: Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention
    homeViral Hepatitis Surveillance – United States
    • 2021 Surveillanceplus icon
      • Overviewplus icon
        • Background
        • National Profile of Viral Hepatitis
        • Technical Notes
      • Hepatitis Aplus icon
        • Figure 1.1 – Number of Cases & Estimated Infections
        • Figure 1.2 – Case Rates by Jurisdiction
        • Figure 1.3 – Map of Case Rates
        • Figure 1.4 – Case Rates by Age Group
        • Figure 1.5 – Case Rates by Sex
        • Figure 1.6 – Case Rates by Race/Ethnicity
        • Figure 1.7 – Risk & Exposure Data
        • Table 1.1 – Number & Rates of Cases by Jurisdiction
        • Table 1.2 – Cases & Rates by Demographics
        • Table 1.3 – Risk & Exposure Data
        • Table 1.4 – Death Rates by Demographics
      • Hepatitis Bplus icon
        • Figure 2.1 – Acute – Number of Cases & Estimated Infections
        • Figure 2.2 – Acute – Case Rates by Jurisdiction
        • Figure 2.3 – Acute – Map of Case Rates
        • Figure 2.4 – Acute – Case Rates by Age Group
        • Figure 2.5 – Acute – Case Rates by Sex
        • Figure 2.6 – Acute – Case Rates by Race/Ethnicity
        • Figure 2.7 – Acute – Risk & Exposure
        • Figure 2.8 – Map of Death Rates
        • Table 2.1 – Acute – Numbers & Rates of Cases
        • Table 2.2 – Acute – Cases & Rates by Demographics
        • Table 2.3 – Acute – Risk & Exposure Data
        • Table 2.4 – Perinatal – Cases by Jurisdiction
        • Table 2.5 – Chronic – Case Rates by Jurisdiction
        • Table 2.6 – Chronic – Case Rates by Demographics
        • Table 2.7 – Death Rates by Jurisdiction
        • Table 2.8 – Death Rates by Demographics
      • Hepatitis Cplus icon
        • Figure 3.1 – Acute – Number of Cases & Estimated Infections
        • Figure 3.2 – Acute – Case Rates by Jurisdiction
        • Figure 3.3 – Acute – Map of Case Rates
        • Figure 3.4 – Acute – Case Rates by Age Group
        • Figure 3.5 – Acute – Case Rates by Sex
        • Figure 3.6 – Acute – Case Rates by Race/Ethnicity
        • Figure 3.7 – Acute – Risk & Exposure Data
        • Figure 3.8 – Chronic – Case Rates by Sex & Age
        • Figure 3.9 – Map of Death Rates
        • Table 3.1 – Acute – Number & Rates of Cases
        • Table 3.2 – Acute – Cases & Rates by Demographics
        • Table 3.3 – Acute – Risk & Exposure Data
        • Table 3.4 – Perinatal – Cases by Jurisdiction
        • Table 3.5 – Chronic – Case Rates by Jurisdiction
        • Table 3.6 – Chronic – Case Rates by Demographics
        • Table 3.7 – Death Rates by Jurisdiction
        • Table 3.8 – Death Rates by Demographics
      • Perinatal Hepatitis B Prevention Programplus icon
        • Figure 4.1 – Outcomes by Birth Cohort Year
        • Table 4.1 – Outcomes by Jurisdiction
      • Appendixplus icon
        • Figure 5.1 – Number of Cases & Estimated Infections for 18–40 Years
        • Table 5.1 – Reported Cases & Estimated Infections – 95% CI
        • Table 5.2 – Acute & Chronic Hepatitis C Cases Confirmed and Probable
        • Table 5.3 – Hepatitis B & C for 18–40 Years
        • Tables & Figures – 2021 Viral Hepatitis Surveillance Report
    • 2020 Surveillanceplus icon
      • Overviewplus icon
        • Background
        • National Profile of Viral Hepatitis
        • Technical Notes
      • Hepatitis Aplus icon
        • Figure 1.1 – Number of Cases & Estimated Infections
        • Figure 1.2 – Case Rates by Jurisdiction
        • Figure 1.3 – Map of Case Rates
        • Figure 1.4 – Case Rates by Age Group
        • Figure 1.5 – Case Rates by Sex
        • Figure 1.6 – Case Rates by Race & Ethnicity
        • Figure 1.7 – Risk & Exposure Data
        • Table 1.1 – Number & Rates of Cases by Jurisdiction
        • Table 1.2 – Cases & Rates by Demographics
        • Table 1.3 – Risk & Exposure Data
        • Table 1.4 – Death Rates by Demographics
      • Hepatitis Bplus icon
        • Figure 2.1 – Acute – Number of Cases & Estimated Infections
        • Figure 2.2 – Acute – Case Rates by Jurisdiction
        • Figure 2.3 – Acute – Map of Case Rates
        • Figure 2.4 – Acute – Case Rates by Age Group
        • Figure 2.5 – Acute – Case Rates by Sex
        • Figure 2.6 – Acute – Case Rates by Race & Ethnicity
        • Figure 2.7 – Acute – Risk & Exposure
        • Figure 2.8 – Map of Death Rates
        • Table 2.1 – Acute – Number & Rates of Cases
        • Table 2.2 – Acute – Cases & Rates by Demographics
        • Table 2.3 – Acute – Risk & Exposure Data
        • Table 2.4 – Perinatal – Cases by Jurisdiction
        • Table 2.5 – Chronic – Case Rates by Jurisdiction
        • Table 2.6 – Chronic – Case Rates by Demographics
        • Table 2.7 – Death Rates by Jurisdiction
        • Table 2.8 – Death Rates by Demographics
      • Hepatitis Cplus icon
        • Figure 3.1 – Acute – Number of Cases & Estimated Infections
        • Figure 3.2 – Acute – Case Rates by Jurisdiction
        • Figure 3.3 – Acute – Map of Case Rates
        • Figure 3.4 – Acute – Case Rates by Age Group
        • Figure 3.5 – Acute – Case Rates by Sex
        • Figure 3.6 – Acute – Case Rates by Race & Ethnicity
        • Figure 3.7 – Acute – Risk & Exposure Data
        • Figure 3.8 – Chronic – Case Rates by Sex & Age
        • Figure 3.9 – Map of Death Rates
        • Table 3.1 – Acute – Number & Rates of Cases
        • Table 3.2 – Acute – Cases & Rates by Demographics
        • Table 3.3 – Acute – Risk & Exposure Data
        • Table 3.4 – Perinatal – Cases by Jurisdiction
        • Table 3.5 – Chronic – Case Rates by Jurisdiction
        • Table 3.6 – Chronic – Case Rates by Demographics
        • Table 3.7 – Death Rates by Jurisdiction
        • Table 3.8 – Death Rates by Demographics
      • Perinatal Hepatitis B Prevention Programplus icon
        • Figure 4.1 – Outcomes by Birth Cohort Year
        • Table 4.1 – Outcomes by Jurisdiction
      • Appendixplus icon
        • Figure 5.1 – Hepatitis B & C Rates 18-40 years
        • Table 5.1 – Estimated infections and 95% CI
        • Table 5.2 – Acute & Chronic Hepatitis C Cases Confirmed and Probable
        • Table 5.3 – Hepatitis B & C Rates 18-40 years
        • Tables & Figures | 2020 Viral Hepatitis Surveillance Report
    • 2019 Surveillanceplus icon
      • Introduction
      • Hepatitis Aplus icon
        • Figure 1.1
        • Figure 1.2
        • Figure 1.3
        • Figure 1.4
        • Figure 1.5
        • Figure 1.6
        • Figure 1.7
        • Table 1.1
        • Table 1.2
        • Table 1.3
        • Table 1.4
      • Hepatitis Bplus icon
        • Figure 2.1
        • Figure 2.2
        • Figure 2.3
        • Figure 2.4
        • Figure 2.5
        • Figure 2.6
        • Figure 2.7
        • Figure 2.8
        • Table 2.1
        • Table 2.2
        • Table 2.3
        • Table 2.4
        • Table 2.5
        • Table 2.6
        • Table 2.7
        • Table 2.8
      • Hepatitis Cplus icon
        • Figure 3.1
        • Figure 3.2
        • Figure 3.3
        • Figure 3.4
        • Figure 3.5
        • Figure 3.6
        • Figure 3.7
        • Figure 3.8
        • Figure 3.9
        • Table 3.1
        • Table 3.2
        • Table 3.3
        • Table 3.4
        • Table 3.5
        • Table 3.6
        • Table 3.7
        • Table 3.8
      • Appendix
      • Supplemental Report
    • 2018 Surveillanceplus icon
      • Introduction
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Appendix
    • 2017 Surveillanceplus icon
      • Hepatitis A Tables and Figures
      • Hepatitis B Tables and Figures
      • Hepatitis C Tables and Figures
    • 2016 Surveillanceplus icon
      • Commentary
      • Table 1.1 Hepatitis C Outbreaks
    • 2015 Surveillanceplus icon
      • Commentary
      • Table 1.1 Hepatitis C Outbreaks
    • 2014 Surveillanceplus icon
      • Commentary
    • 2013 Surveillanceplus icon
      • Commentaryplus icon
        • Erratum
    • 2012 Surveillanceplus icon
      • Commentary
    • 2011 Surveillanceplus icon
      • Commentary
    • 2010 Surveillanceplus icon
      • Commentary
    • 2009 Surveillanceplus icon
      • Commentary
    • 2008 Surveillanceplus icon
      • Commentary
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
    COVID-19 Information
    Viral Hepatitis Home
    • Overview of Viral Hepatitis
    • Statistics & Surveillance
    • Populations & Settings
    • Outbreaks
    • State and Local Partners & Grantees
    • Policy, Programs, and Science
    • Resource Center
    • Global
    • About CDC
    • Contact Us
    • 800-232-4636
    Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
    CONTACT CDC
    Contact Us
    Call 800-232-4636
    Email Us
    ABOUT CDC
    • About CDC
    • Jobs
    • Funding
    POLICIES
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • OIG
    • Nondiscrimination
    • Vulnerability Disclosure Policy
    CONNECT WITH US
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Youtube
    • Pinterest
    • Snapchat
    • Email
    LANGUAGES
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
    • U.S. Department of Health & Human Services
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • Nondiscrimination
    • OIG
    • Vulnerability Disclosure Policy
    • USA.gov
    SAS stats

    Exit Notification / Disclaimer Policy

    Links with this icon indicate that you are leaving the CDC website.
    • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
    • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
    • You will be subject to the destination website's privacy policy when you follow the link.
    • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
    For more information on CDC's web notification policies, see Website Disclaimers.